Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
As of close of business last night, Supernus Pharmaceuticals Inc’s stock clocked out at $33.05, down -4.45% from its previous closing price of $34.59. In other words, the price has decreased by -$4.45 from its previous closing price. On the day, 0.76 million shares were traded.
Ratios:
To gain a deeper understanding of SUPN’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.53 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.61. For the most recent quarter (mrq), Quick Ratio is recorded 1.98 and its Current Ratio is at 2.20. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Cantor Fitzgerald on February 19, 2025, Downgraded its rating to Neutral and sets its target price to $36 from $57 previously.
On January 06, 2025, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $57.
Piper Sandler Downgraded its Overweight to Neutral on September 11, 2024, whereas the target price for the stock was revised from $41 to $36.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 04 ’25 when Bhatt Padmanabh P. sold 9,477 shares for $39.70 per share. The transaction valued at 376,237 led to the insider holds 10,149 shares of the business.
Bhatt Padmanabh P. sold 2,573 shares of SUPN for $101,942 on Jan 27 ’25. The Sr. VP of IP, CSO now owns 10,149 shares after completing the transaction at $39.62 per share. On Jan 28 ’25, another insider, Bhatt Padmanabh P., who serves as the Sr. VP of IP, CSO of the company, sold 700 shares for $39.62 each. As a result, the insider received 27,734 and left with 10,149 shares of the company.
Valuation Measures:
As of this moment, Supernus’s Price-to-Earnings (P/E) ratio for their current fiscal year is 30.94, and their Forward P/E ratio for the next fiscal year is 17.15. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 140.65. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.80 while its Price-to-Book (P/B) ratio in mrq is 1.81.
Stock Price History:
Over the past 52 weeks, SUPN has reached a high of $40.28, while it has fallen to a 52-week low of $25.53. The 50-Day Moving Average of the stock is -11.64%, while the 200-Day Moving Average is calculated to be 0.23%.
Shares Statistics:
A total of 55.22M shares are outstanding, with a floating share count of 52.82M. Insiders hold about 4.35% of the company’s shares, while institutions hold 109.75% stake in the company.
